Enoxaparin Versus Unfractionated Heparin in PCI
NCT00439855 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2100
Last updated 2007-02-26
Summary
Enoxaparin 0.75mg/kg BW is not inferior to weight adjusted unfractionated heparin as anticoagulation for PCI
Conditions
Interventions
- DRUG
-
Enoxaparin i.v.
- DRUG
-
unfractionated heparin
Sponsors & Collaborators
-
Triemli Hospital
lead OTHER
Principal Investigators
-
osmund bertel, MD · Division of Cardiology Triemli Hospital Zurich
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-09-30
- Completion
- 2006-02-28
Countries
- Switzerland
Study Locations
More Related Trials
-
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
NCT04766437 ·Status: COMPLETED ·Phase: PHASE2
-
Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept
NCT03312855 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
NCT03664180 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.
NCT00269880 ·Status: COMPLETED ·Phase: PHASE3
-
Percutaneous Coronary Intervention Versus Medical Treatment for Stable Angina Pectoris
NCT04496648 ·Status: UNKNOWN ·Phase: NA
-
Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
NCT00317395 ·Status: COMPLETED ·Phase: PHASE2
-
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
NCT00043784 ·Status: COMPLETED ·Phase: PHASE3
-
Polymer Free Stent in Acute Coronary Syndrome
NCT03878966 ·Status: UNKNOWN ·Phase: NA
-
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
NCT01076764 ·Status: COMPLETED ·Phase: PHASE3
-
The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI
NCT02658838 ·Status: UNKNOWN ·Phase: PHASE4
-
Antithrombotic Regimens and Outcome
NCT00448461 ·Status: COMPLETED ·Phase: PHASE4
-
Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen
NCT00320229 ·Status: TERMINATED ·Phase: PHASE4
-
(A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention)
NCT01031095 ·Status: COMPLETED ·Phase: PHASE3
-
Add-on Cangrelor in STEMI-triggered Cardiac Arrest
NCT03273075 ·Status: UNKNOWN ·Phase: PHASE4
-
Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
NCT00077792 ·Status: COMPLETED ·Phase: PHASE3
-
PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy
NCT03392948 ·Status: UNKNOWN
-
Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI
NCT00299377 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
NCT01336348 ·Status: COMPLETED ·Phase: PHASE3
-
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
NCT03630055 ·Status: TERMINATED ·Phase: PHASE3
-
Which Therapy for Acute Heart Attacks? (The WEST Study)
NCT00121446 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of IV Cangrelor and Oral Ticagrelor Study
NCT02733341 ·Status: COMPLETED ·Phase: PHASE4
-
How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
NCT01519518 ·Status: COMPLETED ·Phase: PHASE4
-
Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
NCT05247424 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
NCT00093158 ·Status: COMPLETED ·Phase: PHASE3
-
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
NCT04695106 ·Status: RECRUITING ·Phase: PHASE4